These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 38605630)
1. Impact of elevated body mass index (BMI) on cognitive functioning and inflammation in persons with post-COVID-19 condition: a secondary analysis. Le GH; Kwan ATH; Guo Z; Wong S; Badulescu S; Gill H; Teopiz KM; Meshkat S; Ceban F; Phan L; Subramaniapillai M; Di Vincenzo JD; Rosenblat JD; Mansur RB; d'Andrea G; Ho R; Rhee TG; McIntyre RS Acta Neuropsychiatr; 2024 Apr; ():1-7. PubMed ID: 38605630 [TBL] [Abstract][Full Text] [Related]
2. Vortioxetine for the treatment of post-COVID-19 condition: a randomized controlled trial. McIntyre RS; Phan L; Kwan ATH; Mansur RB; Rosenblat JD; Guo Z; Le GH; Lui LMW; Teopiz KM; Ceban F; Lee Y; Bailey J; Ramachandra R; Di Vincenzo J; Badulescu S; Gill H; Drzadzewski P; Subramaniapillai M Brain; 2024 Mar; 147(3):849-857. PubMed ID: 37936330 [TBL] [Abstract][Full Text] [Related]
3. Impacts of metabolic disruption, body mass index and inflammation on cognitive function in post-COVID-19 condition: a randomized controlled trial on vortioxetine. Kwan ATH; Le GH; Guo Z; Ceban F; Teopiz KM; Rhee TG; Ho R; Di Vincenzo JD; Badulescu S; Meshkat S; Cao B; Rosenblat JD; Dev DA; Phan L; Subramaniapillai M; McIntyre RS Ann Gen Psychiatry; 2024 Feb; 23(1):10. PubMed ID: 38424537 [TBL] [Abstract][Full Text] [Related]
4. Impact of Elevated Body Mass Index (BMI) on Hedonic Tone in Persons with Post-COVID-19 Condition: A Secondary Analysis. Le GH; Kwan ATH; Wong S; Guo Z; Teopiz KM; Badulescu S; Meshkat S; d'Andrea G; Ho R; Rhee TG; Cao B; Phan L; Rosenblat JD; Mansur RB; Subramaniapillai M; McIntyre RS Adv Ther; 2024 Feb; 41(2):686-695. PubMed ID: 38114867 [TBL] [Abstract][Full Text] [Related]
5. Assessing the Effects of Metabolic Disruption, Body Mass Index and Inflammation on Depressive Symptoms in Post-COVID-19 Condition: A Randomized Controlled Trial on Vortioxetine. Kwan ATH; Guo Z; Ceban F; Le GH; Wong S; Teopiz KM; Rhee TG; Ho R; Di Vincenzo JD; Badulescu S; Meshkat S; Cao B; Rosenblat JD; d'Andrea G; Dev DA; Phan L; Subramaniapillai M; McIntyre RS Adv Ther; 2024 May; 41(5):1983-1994. PubMed ID: 38520501 [TBL] [Abstract][Full Text] [Related]
6. Subjective and Objective Measures of Cognitive Function are Correlated in Persons with Post-COVID-19 Condition: A Secondary Analysis of a Randomized Controlled Trial. Kwan ATH; Lakhani M; Le GH; Singh G; Teopiz KM; Ceban F; Nijjar CS; Meshkat S; Badulescu S; Ho R; Rhee TG; Vincenzo JDD; Gill H; McIntyre RS medRxiv; 2024 Mar; ():. PubMed ID: 38562707 [TBL] [Abstract][Full Text] [Related]
7. Association between fatigue and depressive symptoms in persons with post-COVID-19 condition: a post hoc analysis. Teopiz KM; Kwan ATH; Le GH; Guo Z; Badulescu S; Ceban F; Meshkat S; Di Vincenzo JD; d'Andrea G; Cao B; Ho R; Rhee TG; Dev DA; Phan L; Subramaniapillai M; Mansur RB; Rosenblat JD; McIntyre RS Curr Med Res Opin; 2024 Jul; 40(7):1203-1209. PubMed ID: 38860901 [TBL] [Abstract][Full Text] [Related]
8. Impact of vortioxetine on psychosocial functioning moderated by symptoms of fatigue in post-COVID-19 condition: a secondary analysis. Badulescu S; Le GH; Wong S; Kwan ATH; Guo Z; Teopiz KM; Phan L; Subramaniapillai M; Rosenblat JD; Mansur RB; McIntyre RS Neurol Sci; 2024 Apr; 45(4):1335-1342. PubMed ID: 38321333 [TBL] [Abstract][Full Text] [Related]
9. Greater Role of Cognitive Impairment Over Fatigue in Post-COVID-19 Quality of Life: A Post-Hoc Analysis of a Randomized Controlled Trial. Kwan ATH; Lakhani M; Le GH; Singh G; Teopiz KM; Guo Z; Ceban F; Dhaliwal KK; Badulescu S; Ho R; Rhee TG; Cao B; d'Andrea G; McIntyre RS medRxiv; 2024 Mar; ():. PubMed ID: 38562760 [TBL] [Abstract][Full Text] [Related]
10. Relationship between anhedonia and psychosocial functioning in post-COVID-19 condition: a Liao S; Teopiz KM; Kwan ATH; Le GH; Wong S; Ballum H; Rhee TG; Badulescu S; Cao B; Guo Z; Meshkat S; Phan L; Subramaniapillai M; Ho R; McIntyre RS Curr Med Res Opin; 2024 Jul; ():1-5. PubMed ID: 38954402 [TBL] [Abstract][Full Text] [Related]
11. Impact of vortioxetine on depressive symptoms moderated by symptoms of anxiety in persons with post-COVID-19 condition: A secondary analysis. Le GH; Kwan ATH; Guo Z; Teopiz KM; Wong S; Meshkat S; d'Andrea G; Ho R; Rhee TG; Cao B; Badulescu S; Phan L; Rosenblat JD; Mansur RB; Subramaniapillai M; McIntyre RS Psychiatry Res; 2024 Jun; 339():116068. PubMed ID: 38954891 [TBL] [Abstract][Full Text] [Related]
12. Impact of Baseline Anxiety on Well-being in People with Post-COVID-19 Condition: A Secondary Analysis. Kleine N; Kwan ATH; Le GH; Guo Z; Phan L; Subramaniapillai M; McIntyre RS CNS Spectr; 2024 Apr; 29(2):150-154. PubMed ID: 38453677 [TBL] [Abstract][Full Text] [Related]
13. Perceived Cognitive Deficits in Patients With Symptomatic SARS-CoV-2 and Their Association With Post-COVID-19 Condition. Liu TC; Yoo SM; Sim MS; Motwani Y; Viswanathan N; Wenger NS JAMA Netw Open; 2023 May; 6(5):e2311974. PubMed ID: 37145596 [TBL] [Abstract][Full Text] [Related]
14. Biomarkers of sustained systemic inflammation and microvascular dysfunction associated with post-COVID-19 condition symptoms at 24 months after SARS-CoV-2-infection. Jacobs LMC; Wintjens MSJN; Nagy M; Willems L; Ten Cate H; Spronk HMH; van Kuijk SMJ; Ghossein-Doha C; Netea MG; Groh LA; van Petersen AS; Warlé MC Front Immunol; 2023; 14():1182182. PubMed ID: 37868959 [TBL] [Abstract][Full Text] [Related]
15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of Vortioxetine on Cognitive Functioning in Working Patients With Major Depressive Disorder. McIntyre RS; Florea I; Tonnoir B; Loft H; Lam RW; Christensen MC J Clin Psychiatry; 2017 Jan; 78(1):115-121. PubMed ID: 27780334 [TBL] [Abstract][Full Text] [Related]
17. The Effects of Vortioxetine on Cognitive Function in Patients with Major Depressive Disorder: A Meta-Analysis of Three Randomized Controlled Trials. McIntyre RS; Harrison J; Loft H; Jacobson W; Olsen CK Int J Neuropsychopharmacol; 2016 Jun; 19(10):. PubMed ID: 27312740 [TBL] [Abstract][Full Text] [Related]
18. Vaccination after developing long COVID: Impact on clinical presentation, viral persistence, and immune responses. Nayyerabadi M; Fourcade L; Joshi SA; Chandrasekaran P; Chakravarti A; Massé C; Paul ML; Houle J; Boubekeur AM; DuSablon C; Boudreau V; Bovan D; Darbinian E; Coleman EA; Vinci S; Routy JP; Hétu PO; Poudrier J; Falcone EL Int J Infect Dis; 2023 Nov; 136():136-145. PubMed ID: 37717649 [TBL] [Abstract][Full Text] [Related]
19. A Network Meta-Analysis Comparing Effects of Various Antidepressant Classes on the Digit Symbol Substitution Test (DSST) as a Measure of Cognitive Dysfunction in Patients with Major Depressive Disorder. Baune BT; Brignone M; Larsen KG Int J Neuropsychopharmacol; 2018 Feb; 21(2):97-107. PubMed ID: 29053849 [TBL] [Abstract][Full Text] [Related]
20. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]